Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns.
Virus Res. 2024 Mar;341:199308. doi: 10.1016/j.virusres.2024.199308. Epub 2024 Jan 11.
Virus Res. 2024.
PMID: 38171391
Free PMC article.
Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.
Merat SJ, Molenkamp R, Wagner K, Koekkoek SM, van de Berg D, Yasuda E, Böhne M, Claassen YB, Grady BP, Prins M, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T.
Merat SJ, et al.
PLoS One. 2016 Oct 24;11(10):e0165047. doi: 10.1371/journal.pone.0165047. eCollection 2016.
PLoS One. 2016.
PMID: 27776169
Free PMC article.
Item in Clipboard
Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus.
Merat SJ, van de Berg D, Bru C, Yasuda E, Breij E, Kootstra N, Prins M, Molenkamp R, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T.
Merat SJ, et al.
J Immunol Methods. 2018 Mar;454:15-26. doi: 10.1016/j.jim.2017.07.015. Epub 2017 Aug 30.
J Immunol Methods. 2018.
PMID: 28855105
Item in Clipboard
Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.
Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, Kootstra NA, Prins M, Ball JK, Bakker AQ, de Jong MD, Spits H, Beaumont T, Schinkel J.
Merat SJ, et al.
J Hepatol. 2019 Jul;71(1):14-24. doi: 10.1016/j.jhep.2019.02.013. Epub 2019 Feb 21.
J Hepatol. 2019.
PMID: 30797052
Item in Clipboard
Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24).
Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, Kootstra NA, Prins M, Ball JK, Bakker AQ, de Jong MD, Spits H, Beaumont T, Schinkel J.
Merat SJ, et al.
J Hepatol. 2020 Oct;73(4):999-1000. doi: 10.1016/j.jhep.2020.07.004. Epub 2020 Aug 1.
J Hepatol. 2020.
PMID: 32753312
No abstract available.
Item in Clipboard
Cite
Cite